Penumbra, Inc. (PEN) · page 13 of 61
The slide highlights a contradiction between the company's regulatory pathway (510(k)) and its valuation relative to PMA-cleared peers.
Activist deck · peer_benchmark · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 3/5
callout 0/1 metric 0/1 paragraph 1/1 table 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 5
callout primary paragraph data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1